Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 15/20 | 0.56 |
| ▸ | CNR2 | P34972 | 13/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.51 |
| ▸ | LTA4H | P09960 | 1/20 | 0.49 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.49 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13411244 | 0.93 | CNR1 (0.64) | CNR1CNR2NR5A1 | |
| SCHEMBL13411228 | 0.93 | CNR1 (0.64) | CNR1CNR2NR5A1 | |
| SCHEMBL13411235 | 0.93 | CNR1 (0.64) | CNR1CNR2NR5A1 | |
| SCHEMBL19231630 | 0.93 | CNR1 (0.64) | CNR1CNR2NR5A1 | |
| SCHEMBL13815332 | 0.91 | CNR1 (0.50) | CNR1CNR2PTGS2LTA4HACHE | |
| SCHEMBL13016545 | 0.89 | PLA2G2A (0.49) | CNR1CNR2LTA4HNR5A1 | |
| SCHEMBL2771611 | 0.89 | LTA4H (0.46) | CNR1CNR2LTA4HNR5A1 | |
| SCHEMBL14051440 | 0.87 | LTA4H (0.55) | CNR1CNR2PTGS2LTA4HNR5A1 | |
| SCHEMBL16959790 | 0.85 | PLA2G2A (0.46) | CNR1CNR2LTA4HNR5A1 | |
| SCHEMBL7307689 | 0.85 | LTA4H (0.59) | CNR1CNR2PTGS2LTA4HNR5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7687600-B2 | Invertible amphiphilic polymers | UNIVERSITY OF MASSACHUSETTS (US) | 2010-03-30 | — | — | US | disclosed |
| US-7687600-B2 | Invertible amphiphilic polymers | UNIVERSITY OF MASSACHUSETTS (US) | 2010-03-30 | — | — | US | disclosed |
| US-7507840-B2 | Acceptor compounds useful for making hyperpolarizable organic chromophores | UNIVERSITY OF WASHINGTON (US) | 2009-03-24 | — | — | US | disclosed |
| US-20070293669-A1 | Invertible amphiphilic polymers | UNIVERSITY OF MASSACHUSETTS | 2007-12-20 | — | — | US | disclosed |
| US-20070293669-A1 | Invertible amphiphilic polymers | UNIVERSITY OF MASSACHUSETTS | 2007-12-20 | — | — | US | disclosed |
| WO-2002077037-A2 | BIARYL MONOMERS AND DENDRITIC POLYMERS DERIVED THEREFROM | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2002-10-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070293669-A1 | Invertible amphiphilic polymers | PHOSPHO1, INF2, AQP1 | CNR1 613/4885CNR2 938/4885PTGS2 3110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.